References of "Schizophrenia Bulletin"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailMultitasking abilities in persons diagnosed with schizophrenia: a new tool and cognitive model.
Laloyaux, Julien ULg; Van der Linden, Martial ULg; Laroi, Frank ULg

in Schizophrenia Bulletin (2015, March), 41(Supplement 1),

Difficulties in everyday life activities are core features of persons diagnosed with schizophrenia, and in particular during multitasking activities (Semkovska et al., 2010). Multitasking refers to ... [more ▼]

Difficulties in everyday life activities are core features of persons diagnosed with schizophrenia, and in particular during multitasking activities (Semkovska et al., 2010). Multitasking refers to activities (e.g. preparing a meal) where the person has to: (a) carry out and alternate between different tasks that vary in terms of priority, difficulty and duration; (b) define the tasks’ targets; (c) and where the person is faced with unexpected problems during the realization of these tasks (Burgess, 2000). However, the cognitive underpinnings of multitasking abilities have never been adequately explored in schizophrenia. Further, only two cognitive models exist in the literature, which are based on student (Logie et al., 2011) and neurological (Burgess et al., 2000) samples. Both of these models suggest three primary constructs: Memory, Planning and Intent. There are, however, several limitations related to the way multitasking abilities were evaluated in these studies. We thus developed a computerized real-life activity task - the Computerized Meeting Preparation Task (CPMT), which was specifically designed to take into account the multitasking nature of certain everyday life activities. Using this task, and based on previous studies (Burgess et al., 2000; Logie et al., 2011), the aim of the present study was to evaluate multitasking abilities in schizophrenia and to do so in a new cognitive model of multitasking that takes into account certain cognitive functions that are not integrated in existing models. Methods: Fifty-seven individuals with schizophrenia and 41 matched healthy controls completed the CMPT. Participants were also evaluated with a battery of cognitive tests. Results: The results suggest that the CMPT possesses good sensitivity and confirmed the three underlying constructs of multitasking (Memory, Planning and Intent), which were found to be underpinned by several cognitive functions and multitasking aspects. Conclusion: Taken together, this new cognitive model and the CMPT could be a good basis for cognitive interventions of multitasking abilities in schizophrenia. Burgess, P.W., 2000. Strategy application disorder: the role of the frontal lobes in human multitasking. Psychol Res 63, 279-288. Logie, R., et al., 2011. Multitasking: multiple, domain-specific cognitive functions in a virtual environment. Mem Cogn 39, 1561-1574. Semkovska, M. et al., 2004. Assessment of executive dysfunction during activities of daily living in schizophrenia. Schizophr Res 69, 289-300. [less ▲]

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailVisual hallucinations in the psychosis-spectrum, and comparative information from neurodegenerative disorders and eye disease
Waters, F; Collerton, D; ffytche, D et al

in Schizophrenia Bulletin (2014), 40

Detailed reference viewed: 13 (2 ULg)
Full Text
Peer Reviewed
See detailAuditory hallucinations in persons with and without a need for care
Johns; Kompus, K; Connell, M et al

in Schizophrenia Bulletin (2014), 40

Detailed reference viewed: 23 (2 ULg)
Full Text
Peer Reviewed
See detailCulture and hallucinations: overview and future directions
Laroi, Frank ULg; Luhrmann, T; Bell, V et al

in Schizophrenia Bulletin (2014), 40

Detailed reference viewed: 21 (4 ULg)
Full Text
Peer Reviewed
See detailInterdisciplinary approaches to the phenomenology of auditory verbal hallucinations
Woods, A; Jones, N; Bernini, M et al

in Schizophrenia Bulletin (2014), 40

Detailed reference viewed: 12 (3 ULg)
Full Text
Peer Reviewed
See detailAuditory hallucinations in schizophrenia and non-schizophrenia populations: A review and integrated model of cognitive mechanisms
Waters, F.; Aleman, A.; Fernyhough, C. et al

in Schizophrenia Bulletin (2012), 38

Detailed reference viewed: 34 (2 ULg)
Full Text
Peer Reviewed
See detailThe characteristic features of auditory verbal hallucinations in clinical and nonclinical groups: state-of-the-art overview and future directions
Laroi, Frank ULg; Sommer, I.; Blom, J. D. et al

in Schizophrenia Bulletin (2012), 38

Detailed reference viewed: 49 (4 ULg)
Full Text
Peer Reviewed
See detailA case series: Evaluation of the metabolic safety of aripiprazole
De Hert, M.; Hanssens, L.; van Winkel, R. et al

in Schizophrenia Bulletin (2007), 33(3), 823-830

Metabolic abnormalities occur frequently in patients treated with antipsychotics and are of growing concern to clinicians. This study sought to determine whether antipsychotic-associated metabolic ... [more ▼]

Metabolic abnormalities occur frequently in patients treated with antipsychotics and are of growing concern to clinicians. This study sought to determine whether antipsychotic-associated metabolic abnormalities identified through intensive monitoring can be reversed by switching to aripiprazole. Recent evidence suggests that aripiprazole may exhibit a favorable metabolic safety profile. The study population is a subset of a large (n > 500) ongoing prospective cohort. Thirty-one consecutive patients with schizophrenia who were started on aripiprazole were included in the study. All patients underwent an extensive metabolic evaluation, including an oral glucose tolerance test, at baseline, at 6 weeks, and at 3 months post switch. Metabolic abnormalities were defined as any of the following: new onset diabetes, impaired fasting glucose, impaired glucose tolerance, metabolic syndrome (MetS) according to various definitions, and dyslipidemia. After 3 months of treatment with aripiprazole (mean daily dose 16.3 mg), there was a significant decrease in body weight, body mass index, and waist circumference. There was a significant reduction in fasting glucose, fasting insulin, insulin resistance index, and serum lipids levels (cholesterol, triglycerides, low-density lipoprotein (LDL), LDL/HDL, Chol/HDL, and non-HDL cholesterol). There was also a significant reduction in prolactin levels. All 7 cases of recent onset diabetes were reversed at 3 months follow-up. The MetS was reversed in 50% of patients at 3 months follow-up. Our results support the reversibility of recent onset diabetes on antipsychotic medication when detected early and followed by a switch to aripiprazole. [less ▲]

Detailed reference viewed: 25 (0 ULg)